Medicare weight-loss drug coverage could overwhelm doctors

Next month's launch of a Medicare program providing weight-loss drugs for $50 a month is expected to unleash pent-up demand for Wegovy, Zepbound and other blockbuster treatments — and create new bottlenecks at doctors' offices.The big picture: It could become one of the biggest drug rollouts ever — and it could test an already burdened system as seniors seek new GLP-1 prescriptions.Clinicians worry that could also give short shrift to patient counseling on how to take the injectables and pills,...